Announcements Trials

Browse Landscape

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 50 Carcinoma, Non-Small-Cell Lung 39 Carcinoma, Renal Cell 28 Carcinoma, Hepatocellular 18 Neoplasm Metastasis 16 Neoplasms 15 Colorectal Neoplasms 15 Stomach Neoplasms 13 Lung Neoplasms 13 Adenocarcinoma Of Esophagus 11 Squamous Cell Carcinoma of Head and Neck 10 Carcinoma, Transitional Cell 8 Brain Neoplasms 8 Hodgkin Disease 7 Skin Neoplasms 6 Sarcoma 6 Esophageal Neoplasms 6 Clear-cell metastatic renal cell carcinoma 6 Triple Negative Breast Neoplasms 5 Prostatic Neoplasms 5 Pancreatic Neoplasms 5 Kidney Neoplasms 5 Carcinoma, Merkel Cell 5 Uveal Melanoma 4 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Recurrence 4 Neuroendocrine Tumors 4 Nasopharyngeal Carcinoma 4 Mesothelioma 4

Interventions

Exercise 36 Nutritional Status 5 Control Groups 4 Resistance Training 3 High-Intensity Interval Training 3 lime 2 Vitamin D 2 Standard of Care 2 Preoperative Exercise 2 Dosage Forms 2 Diet 2 tislelizumab 1 pembrolizumab 1 oncomodulin 1 diacetamate 1 blueberry extract 1 beta-Glucans 1 Whey Proteins 1 Wearable Electronic Devices 1 Walking 1 Transcranial Direct Current Stimulation 1 Tea 1 Tablets 1 TEMPO 1 Spermine Synthase 1 Roflumilast 1 Rehabilitation 1 Radiotherapy 1 Probiotics 1 Physical Therapy Modalities 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Motor Activity × Nivolumab × Clear all

NCT06627595 2024-11-15

APiTOXMM

University Hospital, Montpellier

Melanoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡